?-Catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation
Citations Over TimeTop 10% of 2004 papers
Abstract
Mutations of critical components of the Wnt pathway profoundly affect skeletal development and maintenance, probably via modulation of beta-catenin signaling. We tested the hypothesis that beta-catenin is involved in mesenchymal lineage allocation to osteogenic cells using a beta-catenin mutant with constitutive transcriptional activity (DeltaN151). Although this stable beta-catenin had no effects by itself on osteogenic differentiation of multipotent embryonic cell lines, it synergized with bone morphogenetic protein-2 (BMP-2) resulting in dramatic stimulation of alkaline phosphatase activity, osteocalcin gene expression, and matrix mineralization. Likewise, DeltaN151 and BMP-2 synergistically stimulated new bone formation after subperiosteal injection in mouse calvaria in vivo. Conversely, DeltaN151 prevented adipogenic differentiation from pre-adipocytic or uncommitted mesenchymal cells in vitro. Intriguingly, the synergism with BMP-2 on gene transcription occurred without altering expression of Cbfa1/Runx2, suggesting actions independent or downstream of this osteoblast-specific transcription factor. Thus, beta-catenin directs osteogenic lineage allocation by enhancing mesenchymal cell responsiveness to osteogenic factors, such as BMP-2, in part via Tcf/Lef dependent mechanisms. In vivo, this synergism leads to increased new bone formation.
Related Papers
- → Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells(2010)113 cited
- → O-GlcNAc modification modulates the expression of osteocalcin via OSE2 and Runx2(2007)46 cited
- → Novel bone Morphogenetic Protein (BMP)-2/4 Consensus Peptide (BCP)for the Osteogenic Differentiation of C2C12 Cells(2023)3 cited
- → Upregulation of smpd3 via BMP2 stimulation and Runx2(2009)26 cited
- [Evaluation of osteogenic effects of BMP2 up-regulator E40071 in vitro].(2016)